IntegriChain, the leading provider of revenue optimization technology and insights for the pharmaceutical industry, announced the appointment of Matt Heyman as Chief Financial Officer. Heyman brings IntegriChain more than a decade of experience in corporate finance, strategy, and M&A, predominately within public and private software businesses.
Read More: Calabrio Introduces All-in-One Compliance Recording Solution for Webex Calling
“IntegriChain is poised for significant growth in the coming years as we focus on our mission – to help pharma innovators develop, implement, and operate sustainable growth strategies for life-changing science,” said Josh Halpern, Co-Founder and CEO of IntegriChain. “We are thrilled to have Matt join us with his depth of experience in corporate finance and development, growing SaaS companies, and partnering with strategic investors.”
Read More: SalesTechStar Interview with Chris Nelson, VP, Global Sales and Business Development, HYCU, Inc.
“I am excited to join the IntegriChain leadership team at this pivotal moment,” said Heyman. “The company has developed into a leading platform that uniquely combines data, technology, outsourcing, and consulting to address the essential challenges of drug commercialization in today’s market. I look forward to helping IntegriChain execute its vision organically and inorganically as we continue to build out the ICyte Platform and arm our pharma customers with the keys they need to deliver renewed growth.”
